Living Cell Technologies Ltd. (AU:1AI) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Algorae Pharmaceuticals has appointed Dr. Sarah Siggins to its Scientific Advisory Board, a move expected to bolster its AI-driven drug discovery efforts. With her extensive experience at Johnson & Johnson and Bristol-Myers Squibb, Dr. Siggins is set to provide strategic advice on commercial partnerships for the company’s innovative therapies. This appointment marks a significant step in Algorae’s efforts to advance its pipeline of AI-generated drug candidates.
For further insights into AU:1AI stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- What If Elon Musk Actually Did Buy the Comcast (NASDAQ:CMCSA) Channels?
- Long John Silver: Pirate, Mutineer, and Personal Finance Guru?
- ETH, ETHQ, ETHX: 3 Ethereum ETFs to Boost Portfolio Returns
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
